- Home
- SEE vs STVN Comparison
SEE vs STVN Comparison
Compare SEE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEE
- STVN
- Stock Information
- Founded
- SEE 1960
- STVN 1949
- Country
- SEE United States
- STVN Italy
- Employees
- SEE N/A
- STVN N/A
- Industry
- SEE Major Chemicals
- STVN Containers/Packaging
- Sector
- SEE Industrials
- STVN Consumer Discretionary
- Exchange
- SEE Nasdaq
- STVN Nasdaq
- Market Cap
- SEE 5.3B
- STVN 6.2B
- IPO Year
- SEE N/A
- STVN 2021
- Fundamental
- Price
- SEE $35.49
- STVN $22.22
- Analyst Decision
- SEE Buy
- STVN Buy
- Analyst Count
- SEE 13
- STVN 6
- Target Price
- SEE $40.00
- STVN $27.50
- AVG Volume (30 Days)
- SEE 1.2M
- STVN 328.8K
- Earning Date
- SEE 02-25-2025
- STVN 03-06-2025
- Dividend Yield
- SEE 2.26%
- STVN 0.25%
- EPS Growth
- SEE 26.45
- STVN N/A
- EPS
- SEE 2.72
- STVN 0.48
- Revenue
- SEE $5,397,300,000.00
- STVN $1,220,254,294.00
- Revenue This Year
- SEE N/A
- STVN $3.01
- Revenue Next Year
- SEE $0.99
- STVN $7.07
- P/E Ratio
- SEE $13.10
- STVN $48.10
- Revenue Growth
- SEE N/A
- STVN 3.53
- 52 Week Low
- SEE $30.87
- STVN $16.56
- 52 Week High
- SEE $41.14
- STVN $34.73
- Technical
- Relative Strength Index (RSI)
- SEE 58.33
- STVN 50.77
- Support Level
- SEE $34.22
- STVN $21.42
- Resistance Level
- SEE $34.83
- STVN $24.38
- Average True Range (ATR)
- SEE 0.72
- STVN 1.28
- MACD
- SEE 0.23
- STVN -0.12
- Stochastic Oscillator
- SEE 95.29
- STVN 42.32
About SEE Sealed Air Corporation
Sealed Air is organized via two reporting segments. Food care includes food packaging products like Cryovac, Darfresh, and OptiDure aimed primarily at meats. Product care includes Sealed Air's Bubble Wrap, Instapak, Jiffy mailers, and shrink film packaging systems that cater to industrial and e-commerce applications.
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.